Journal Home Online First Current Issue Archive For Authors Journal Information 中文版

Engineering >> 2022, Volume 10, Issue 3 doi: 10.1016/j.eng.2022.02.001

In Vivo Development of Fetal Pig Kidneys in Mature Monkeys Under Clinically Approved Immunosuppressant Drugs

a Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan
b Department of Urology, The Jikei University School of Medicine, Tokyo 105-8461, Japan
c Department of Plastic and Reconstructive Surgery, The Jikei University School of Medicine, Tokyo 105-8461, Japan
d Meiji University International Institute for Bio-Resource Research, Kanagawa 214-8571, Japan
e Sumitomo Dainippon Pharma Co., Ltd., Osaka-fu 564-0053, Japan
f Department of Kidney Regenerative Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan

Received: 2021-07-06 Revised: 2021-12-24 Accepted: 2022-02-07 Available online: 2022-02-22

Next Previous

Abstract

Controlling the immune response with only clinically approved immunosuppressant drugs is difficult in renal heterotransplantation from pigs to nonhuman primates. Moreover, to the best of our knowledge, no reports exist on the use of fetal pigs as kidney donors. This study aimed to compare the degree of transplant rejection between neonatal and fetal kidneys, with genetically unmodified pigs as donors and cynomolgus monkeys as recipients. The left kidneys of the recipient monkeys were removed, followed by transplantation of neonatal as well as fetal pig kidneys, which had undergone vascular anastomosis at the same site, into the retroperitoneum. Immunosuppression was performed with only US Food and Drug Administration-approved drugs. The fetal kidneys were transplanted into the omentum and paraaortic regions of cynomolgus monkeys. Consequently, the engraftment and development of the transplanted tissues were pathologically examined by sampling over time (twice in each experiment). An acute rejection was observed after a few weeks in neonatal renal grafts with vascular anastomosis. However, fetal pig kidneys were spared from rejection despite the administration of the same immunosuppressive protocol to the monkeys and the recipient blood vessels flowing into the fetal kidneys. The immunogenicity of fetal kidneys in pig–monkey renal heterotransplantation was lower than that of neonatal kidneys.

Figures

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

Fig. 7

Fig. 8

Fig. 9

References

[ 1 ] Qi S, Peng J, Xu D, Vu MD, Liu D, Chen H. Improved techniques for kidney transplantation in the monkey. Microsurgery 1999;19(7):335–7. link1

[ 2 ] Takamura T, Sasaki H, Hirayama H, Kiyoshi A, Inoue M, Matsui K, et al. Techniques of orthotopic renal transplantation. II. Size-matched porcine grafts in monkey recipients. Acta Cir Bras 36 5 2021;36(5):e360503.

[ 3 ] Iwase H, Hara H, Ezzelarab M, Li T, Zhang Z, Gao B, et al. Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts. Xenotransplantation 2017;24(2):e12293. link1

[ 4 ] Higginbotham L, Mathews D, Breeden CA, Song M, Farris AB, Larsen CP, et al. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model. Xenotransplantation 2015;22(3):221–30. link1

[ 5 ] Kim SC, Mathews DV, Breeden CP, Higginbotham LB, Ladowski J, Martens G, et al. Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion. Am J Transplant 2019;19(8):2174–85. link1

[ 6 ] Yamamoto T, Hara H, Foote J, Wang L, Li Q, Klein EC, et al. Life-supporting kidney xenotransplantation from genetically engineered pigs in baboons: a comparison of two immunosuppressive regimens. Transplantation 2019;103 (10):2090–104. link1

[ 7 ] Fujimoto T, Yamanaka S, Tajiri S, Takamura T, Saito Y, Matsumoto N, et al. Generation of human renal vesicles in mouse organ niche using nephron progenitor cell replacement system. Cell Rep 2020;32(11):108130. link1

[ 8 ] Yokoo T, Yamanaka S, Kobayashi E. Xeno-regenerative medicine: a novel concept for donor kidney fabrication. Xenotransplantation 2020;27(5): e12622. link1

[ 9 ] Dekel B, Burakova T, Arditti FD, Reich-Zeliger S, Milstein O, Aviel-Ronen S, et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med 2003;9(1):53–60. link1

[10] Takeda S-I, Rogers SA, Hammerman MR. Differential origin for endothelial and mesangial cells after transplantation of pig fetal renal primordia into rats. Transpl Immunol 2006;15(3):211–5. link1

[11] Matsumoto K, Yokoo T, Matsunari H, Iwai S, Yokote S, Teratani T, et al. Xenotransplanted embryonic kidney provides a niche for endogenous mesenchymal stem cell differentiation into erythropoietin-producing tissue. Stem cells 2012;30(6):1228–35.

[12] Dekel B, Burakova T, Ben-Hur H, Marcus H, Oren R, Laufer J, et al. Engraftment of human kidney tissue in rat radiation chimera: II. Human fetal kidneys display reduced immunogenicity to adoptively transferred human peripheral blood mononuclear cells and exhibit rapid growth and development. Transplantation 1997;64(11):1550–8. link1

[13] Li Q, Iwase H, Yamamoto T, Nguyen HQ, Ayares D, Wang Y, et al. Anti-pig IgE and IgA antibodies in naive primates and nonhuman primates with pig xenografts. Transplantation 2021;105(2):318–27. link1

[14] Yokote S, Matsunari H, Iwai S, Yamanaka S, Uchikura A, Fujimoto E, et al. Urine excretion strategy for stem cell-generated embryonic kidneys. Proc Natl Acad Sci USA 2015;112(42):12980–5. link1

Related Research